about
REPLACE: a strategy for iterative design of cyclin-binding groove inhibitors.The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.Anti-apoptotic effects of PCP4/PEP19 in human breast cancer cell lines: a novel oncotargetMultidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia.Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cellsTherapeutic potential of ERK5 targeting in triple negative breast cancerNCI's provocative questions on cancer: some answers to ignite discussion.Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cellsRecent progress in the discovery and development of cyclin-dependent kinase inhibitors.Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.Recent advances on structure-informed drug discovery of cyclin-dependent kinase-2 inhibitors.Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTOR.
P2860
Q30357531-2AAE713C-543A-4F7F-BD7B-76C88B8F3BFEQ34227548-37AC27DC-A6CB-4638-A4F2-B49D75A41565Q34227603-1188D85A-B994-4548-95B7-413C5812276BQ34619344-F501A32F-2BD9-4546-BE09-B0A6EF3A2809Q34786462-02FFD061-874D-43C8-921A-273658BB54A1Q34956816-54C8DB02-E401-4486-A07D-A9789D91C39BQ35764401-7DA1EB31-B634-4F3D-A2DD-6267E2DF510BQ35832986-2E555D23-7361-49FF-BF4C-6701DFDC5306Q36120794-6654CD6F-FA65-4A68-A916-773177496805Q36356167-DBACFCA0-5777-444C-B1B8-C78624F12F50Q37855864-7C622272-CA11-40DD-8F04-17917D42A3F4Q41860750-CF633B9F-2B97-4605-861E-39D60E3ACD44
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Do cells need CDK2 and ... Bcr-Abl?
@en
Do cells need CDK2 and ... Bcr-Abl?
@nl
type
label
Do cells need CDK2 and ... Bcr-Abl?
@en
Do cells need CDK2 and ... Bcr-Abl?
@nl
prefLabel
Do cells need CDK2 and ... Bcr-Abl?
@en
Do cells need CDK2 and ... Bcr-Abl?
@nl
P2860
P356
P1476
Do cells need CDK2 and ... Bcr-Abl?
@en
P2093
Blagosklonny MV
P2860
P2888
P304
P356
10.1038/SJ.CDD.4401361
P577
2004-03-01T00:00:00Z